New study sheds light on efficacy of ADHD meds

Article

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Peter S. Jensen, MD
Rakesh Jain, MD, MPH
Rakesh Jain, MD, MPH
Alan Percy, MD
Alan Percy, MD
Perry Roy, MD
Perry Roy, MD | Image Credit: Carolina Attention Specialists
Related Content
FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk | Image Credit: Contemporary Pediatrics

FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk

Joshua Fitch, Senior Editor
July 1st 2025
Article

The revised labeling will warn that patients younger than 6 years taking these medications are at greater risk of weight loss.

ADHD Medications: A Look at Their Safety Profile

ADHD Medications: A Look at Their Safety Profile

Joan Daughton, MD
October 17th 2012
Podcast

Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.

AAP updates guidance on genetic testing for developmental delay | Image Credit: © Cavan - stock.adobe.com.

AAP updates guidance on genetic testing for developmental delay

Morgan Ebert, Managing Editor
June 23rd 2025
Article

AAP updates clinical guidance to help pediatricians navigate genetic evaluation of children with global developmental delay or intellectual disability.

Artificial intelligence improves accuracy in estimating child abuse | Image Credit: © mihakonceptcorn - stock.adobe.com.

Artificial intelligence improves accuracy in estimating child abuse

Morgan Ebert, Managing Editor
April 27th 2025
Article

New model refines prevalence estimates, reduces misdiagnoses compared to the current coding system.

Image Credit: © EKKAPON - stock.adobe.com.

CBD may ease autism symptoms in children

Morgan Ebert, Managing Editor
April 9th 2025
Article

CBD cannabis extract may improve social responsiveness and reduce disruptive behavior in children with autism, with no increase in adverse effects, according to a recent study

Pediatric FDA, clinical trial, and interview recap from Q1 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

Q1 2025: A recap of the top headlines and interviews

Joshua Fitch, Senior Editor ;Morgan Ebert, Managing Editor
April 3rd 2025
Article

View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

© 2025 MJH Life Sciences

All rights reserved.